Ralf Hoffmann

12.8k total citations
320 papers, 10.2k citations indexed

About

Ralf Hoffmann is a scholar working on Molecular Biology, Microbiology and Clinical Biochemistry. According to data from OpenAlex, Ralf Hoffmann has authored 320 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Molecular Biology, 79 papers in Microbiology and 43 papers in Clinical Biochemistry. Recurrent topics in Ralf Hoffmann's work include Antimicrobial Peptides and Activities (74 papers), Advanced Glycation End Products research (41 papers) and Mass Spectrometry Techniques and Applications (36 papers). Ralf Hoffmann is often cited by papers focused on Antimicrobial Peptides and Activities (74 papers), Advanced Glycation End Products research (41 papers) and Mass Spectrometry Techniques and Applications (36 papers). Ralf Hoffmann collaborates with scholars based in Germany, United States and Australia. Ralf Hoffmann's co-authors include Daniel Knappe, Maria Fedorova, Andrej Frolov, Ravi Chand Bollineni, László Ötvös, David Singer, László Ötvös, Sanja Milkovska‐Stamenova, Daniela Volke and Sándor Lovas and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Ralf Hoffmann

311 papers receiving 10.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralf Hoffmann Germany 51 5.9k 2.5k 1.3k 1.2k 969 320 10.2k
Bradford W. Gibson United States 71 10.1k 1.7× 2.3k 0.9× 444 0.4× 1.8k 1.6× 1.3k 1.3× 224 16.1k
Andrea Scaloni Italy 63 7.4k 1.3× 567 0.2× 386 0.3× 865 0.7× 656 0.7× 403 13.5k
Hermann Schägger Germany 62 21.6k 3.7× 936 0.4× 2.2k 1.8× 1.7k 1.5× 1.3k 1.4× 122 28.0k
Hans Jörnvall Sweden 92 17.6k 3.0× 2.3k 0.9× 1.0k 0.8× 2.0k 1.7× 2.2k 2.3× 542 31.0k
Charles O. Rock United States 82 13.6k 2.3× 1.8k 0.7× 1.2k 0.9× 427 0.4× 719 0.7× 273 20.5k
Gebhard von Jagow Germany 40 12.1k 2.1× 697 0.3× 686 0.5× 925 0.8× 946 1.0× 72 16.8k
Uwe Völker Germany 64 8.1k 1.4× 452 0.2× 382 0.3× 917 0.8× 913 0.9× 426 14.6k
Roland Benz Germany 78 13.8k 2.4× 2.0k 0.8× 896 0.7× 800 0.7× 1.9k 2.0× 445 21.4k
Rong Wang China 54 7.8k 1.3× 571 0.2× 360 0.3× 1.2k 1.0× 1.8k 1.8× 498 13.9k
William Dowhan United States 67 11.2k 1.9× 499 0.2× 1.1k 0.8× 714 0.6× 348 0.4× 166 13.9k

Countries citing papers authored by Ralf Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Ralf Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Hoffmann more than expected).

Fields of papers citing papers by Ralf Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Hoffmann. The network helps show where Ralf Hoffmann may publish in the future.

Co-authorship network of co-authors of Ralf Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Hoffmann. A scholar is included among the top collaborators of Ralf Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Hoffmann. Ralf Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krizsan, Andor, et al.. (2025). The proline-rich antimicrobial peptide Api137 disrupts large ribosomal subunit assembly and induces misfolding. Nature Communications. 16(1). 567–567. 1 indexed citations
3.
Dunker, Susanne, Ralf Hoffmann, Raimund Nagel, et al.. (2025). Extensive remodeling during Chlamydomonas reinhardtii zygote maturation leads to highly resistant zygospores. The Plant Journal. 121(3). e17238–e17238. 2 indexed citations
4.
Spiegeleer, Anton De, Evelien Wynendaele, Marta Planas, et al.. (2024). Streptococcal quorum sensing peptide CSP-7 contributes to muscle inflammation and wasting. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(4). 167094–167094. 4 indexed citations
5.
Klepacki, Dorota, Helmut Grubmüller, Lars V. Bock, et al.. (2024). Multimodal binding and inhibition of bacterial ribosomes by the antimicrobial peptides Api137 and Api88. Nature Communications. 15(1). 3945–3945. 9 indexed citations
6.
Jassoy, Christian, et al.. (2024). Potential of a Bead-Based Multiplex Assay for SARS-CoV-2 Antibody Detection. Biology. 13(4). 273–273. 1 indexed citations
7.
Moors, Marco, Markus Rohdenburg, Xue‐Bin Wang, et al.. (2024). Ligand Substituent Effects on the Electronic Properties of Lindqvist‐Type Polyoxometalate Multi‐Level‐Switches in the Gas Phase, Solution and on Surfaces. Advanced Materials Interfaces. 11(33). 7 indexed citations
8.
Ding, Wenjin, Ralf Hoffmann, Louis Sieuw, et al.. (2023). AlCl3-NaCl-ZnCl2 Secondary Electrolyte in Next-Generation ZEBRA (Na-ZnCl2) Battery. Batteries. 9(8). 401–401. 4 indexed citations
9.
Klepacki, Dorota, Weiping Huang, Andor Krizsan, et al.. (2023). Inhibition of translation termination by the antimicrobial peptide Drosocin. Nature Chemical Biology. 19(9). 1082–1090. 34 indexed citations
11.
Almaaytah, Ammar, et al.. (2018). Antimicrobial and Antibiofilm Activity of UP-5, an Ultrashort Antimicrobial Peptide Designed Using Only Arginine and Biphenylalanine. Pharmaceuticals. 11(1). 3–3. 42 indexed citations
13.
Böttger, Roland, Ralf Hoffmann, & Daniel Knappe. (2017). Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum. PLoS ONE. 12(6). e0178943–e0178943. 230 indexed citations
14.
Frolov, Andrej, et al.. (2015). Oxidative degradation of N ε-fructosylamine-substituted peptides in heated aqueous systems. Amino Acids. 47(5). 1065–1076. 19 indexed citations
15.
Knappe, Daniel, Knut Adermann, & Ralf Hoffmann. (2015). Oncocin Onc72 is efficacious against antibiotic‐susceptible Klebsiella pneumoniae ATCC 43816 in a murine thigh infection model. Biopolymers. 104(6). 707–711. 27 indexed citations
16.
Annibal, Andrea, Maria Fedorova, Jürgen Schiller, & Ralf Hoffmann. (2014). In vitro glycation and glycoxidation of phosphatidylethanolamines. Free Radical Biology and Medicine. 75. S21–S22. 2 indexed citations
17.
Singer, David, et al.. (2010). Synthesis of pathological and nonpathological human exon 1 huntingtin. Journal of Peptide Science. 16(7). 358–363. 15 indexed citations
18.
Frolov, Andrej, David Singer, & Ralf Hoffmann. (2007). Solid‐phase synthesis of glucose‐derived Amadori peptides. Journal of Peptide Science. 13(12). 862–867. 22 indexed citations
19.
Hagner, Stefanie, Rainer Haberberger, D. Overkamp, et al.. (2002). Expression and distribution of calcitonin receptor-like receptor in human hairy skin. Peptides. 23(1). 109–116. 36 indexed citations
20.
Hoffmann, Ralf, Philippe Bulet, László Ürge, & László Ötvös. (1999). Range of activity and metabolic stability of synthetic antibacterial glycopeptides from insects. Biochimica et Biophysica Acta (BBA) - General Subjects. 1426(3). 459–467. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026